Cassava Sciences
SAVA
#9221
Rank
S$0.13 B
Marketcap
S$2.81
Share price
-23.68%
Change (1 day)
-9.84%
Change (1 year)

Earnings for Cassava Sciences (SAVA)

Earnings in 2025 (TTM): -S$0.15 Billion

According to Cassava Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$0.19 Billion a decrease over its 2023 earnings that were of -S$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cassava Sciences from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.15 Billion-19.94%
2024 -S$0.19 Billion34.28%
2023 -S$0.14 Billion32.41%
2022 -S$0.11 Billion143.46%
2021 -S$42.49 Million383.92%
2020 -S$8.78 Million36.96%
2019 -S$6.41 Million-25.56%
2018 -S$8.62 Million-44.25%
2017 -S$15.45 Million-20.11%
2016 -S$19.34 Million5.32%
2015 -S$18.36 Million14.23%
2014 -S$16.07 Million-139.64%
2013 S$40.53 M
2010 -S$17.71 Million102.87%
2009 -S$8.73 Million-177.52%
2008 S$11.26 M-14.32%
2007 S$13.14 M-1942.21%
2006 -S$0.72 Million
2004 -S$50.36 Million75.1%
2003 -S$28.76 Million
2001 -S$22.38 Million20.49%
2000 -S$18.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.2 Billion 31.98%๐Ÿ‡บ๐Ÿ‡ธ USA